Creative Biolabs-Immuno-oncology

Anti-CD22 (clone IRO30) SynExpress C-G-NF-B CD4+ T Cells (CAT#: ITS-1124-CR13)

DatasheetDatasheet
Description
This product utilizes CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone IRO30). We employs the Retrovirus (CMV-GFP-NF-κB-BamHI) vector components and the SynExpress system of the coding regions Deletion/Positive feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD22
Clone
IRO30
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
GFP
Promoter
CMV
Effector Gene
NF-κB
Insertion Sites
BamHI
Gene Modification
Deletion
Modification Domain
Coding regions
Carrier Type
Retrovirus
Transformation Accuracy
0.88
Cell Culture
Suspension Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.